CHICAGO HIGHLIGHTS 2024 – GI ROUNDTABLE DISCUSSION: ARMANI
OR
Chair
Dr. Scott Berry
Panelists
Dr. Sharlene Gill
Dr. Florian Lordick
Studies/trials discussed:
- Ramucirumab plus paclitaxel as switch maintenance versus continuation of oxaliplatin-based chemotherapy in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction (GEJ) cancer: The ARMANI phase III trial.
